Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 3085 to 3095 of 3095 entries
Sorted by: Best Match Show Resources per page
Beowulf single-authorship claim is unsupported.

Nature human behaviour

Plecháč P, Cooper A, Nagy B, Šeļa A.
PMID: 34764463
Nat Hum Behav. 2021 Nov;5(11):1481-1483. doi: 10.1038/s41562-021-01222-5. Epub 2021 Nov 11.

No abstract available.

Cite
Plecháč P, Cooper A, Nagy B, et al. Beowulf single-authorship claim is unsupported. Nat Hum Behav. 2021;5(11):1481-1483doi: 10.1038/s41562-021-01222-5.
Plecháč, P., Cooper, A., Nagy, B., & Šeļa, A. (2021). Beowulf single-authorship claim is unsupported. Nature human behaviour, 5(11), 1481-1483. https://doi.org/10.1038/s41562-021-01222-5
Plecháč, Petr, et al. "Beowulf single-authorship claim is unsupported." Nature human behaviour vol. 5,11 (2021): 1481-1483. doi: https://doi.org/10.1038/s41562-021-01222-5
Plecháč P, Cooper A, Nagy B, Šeļa A. Beowulf single-authorship claim is unsupported. Nat Hum Behav. 2021 Nov;5(11):1481-1483. doi: 10.1038/s41562-021-01222-5. Epub 2021 Nov 11. PMID: 34764463.
Copy Download .nbib Format: NLM
Which came first, T cells or B cells?.

Nature reviews. Immunology

Cooper M.
PMID: 34580447
Nat Rev Immunol. 2021 Oct;21(10):616-617. doi: 10.1038/s41577-021-00593-0.

No abstract available.

Cite
Cooper M. Which came first, T cells or B cells?. Nat Rev Immunol. 2021;21(10):616-617doi: 10.1038/s41577-021-00593-0.
Cooper, M. (2021). Which came first, T cells or B cells?. Nature reviews. Immunology, 21(10), 616-617. https://doi.org/10.1038/s41577-021-00593-0
Cooper, Max. "Which came first, T cells or B cells?." Nature reviews. Immunology vol. 21,10 (2021): 616-617. doi: https://doi.org/10.1038/s41577-021-00593-0
Cooper M. Which came first, T cells or B cells?. Nat Rev Immunol. 2021 Oct;21(10):616-617. doi: 10.1038/s41577-021-00593-0. PMID: 34580447.
Copy Download .nbib Format: NLM
Statistics: a learning needs assessment.

Medical teacher

Creanor S, Cooper N, Creanor SL.
PMID: 21966689
Med Teach. 2011;33(9):775-6.

No abstract available.

Cite
Creanor S, Cooper N, Creanor SL. Statistics: a learning needs assessment. Med Teach. 2011;33(9):775-6
Creanor, S., Cooper, N., & Creanor, S. L. (2011). Statistics: a learning needs assessment. Medical teacher, 33(9), 775-6.
Creanor, Siobhan, et al. "Statistics: a learning needs assessment." Medical teacher vol. 33,9 (2011): 775-6.
Creanor S, Cooper N, Creanor SL. Statistics: a learning needs assessment. Med Teach. 2011;33(9):775-6. PMID: 21966689.
Copy Download .nbib Format: NLM
A review of influenza vaccine immunogenicity and efficacy in HIV-infected adults.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale

Cooper C, Hutton B, Fergusson D, Mills E, Klein MB, Boivin G, Halperin S.
PMID: 19436572
Can J Infect Dis Med Microbiol. 2008 Nov;19(6):419-23. doi: 10.1155/2008/419710.

BACKGROUND: HIV-seropositive adults are at an increased risk for influenza infection. They also develop more severe influenza disease and are hyporesponsive to current influenza vaccinations.METHODS: The authors examined findings from a systematic review of influenza vaccination in HIV-seropositive adults,...

Cite
Cooper C, Hutton B, Fergusson D, et al. A review of influenza vaccine immunogenicity and efficacy in HIV-infected adults. Can J Infect Dis Med Microbiol. 2008;19(6):419-23doi: 10.1155/2008/419710.
Cooper, C., Hutton, B., Fergusson, D., Mills, E., Klein, M. B., Boivin, G., & Halperin, S. (2008). A review of influenza vaccine immunogenicity and efficacy in HIV-infected adults. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 19(6), 419-23. https://doi.org/10.1155/2008/419710
Cooper, Curtis, et al. "A review of influenza vaccine immunogenicity and efficacy in HIV-infected adults." The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale vol. 19,6 (2008): 419-23. doi: https://doi.org/10.1155/2008/419710
Cooper C, Hutton B, Fergusson D, Mills E, Klein MB, Boivin G, Halperin S. A review of influenza vaccine immunogenicity and efficacy in HIV-infected adults. Can J Infect Dis Med Microbiol. 2008 Nov;19(6):419-23. doi: 10.1155/2008/419710. PMID: 19436572; PMCID: PMC2663473.
Copy Download .nbib Format: NLM
Relationship between burnout and mistreatment: Who plays a role?.

American journal of surgery

Baker S, Gleason F, Lovasik B, Sandhu G, Cortez A, Hildreth A, Cooper A, Simmons J, Delman KA, Lindeman B.
PMID: 34325910
Am J Surg. 2021 Dec;222(6):1060-1065. doi: 10.1016/j.amjsurg.2021.06.009. Epub 2021 Jul 22.

INTRODUCTION: Surgery residents have high burnout rates and mistreatment occurs during training. We hypothesized that residents who reported mistreatment would be more likely to experience burnout.METHODS: A multi-institutional observational study asked residents to complete the Maslach Burnout Inventory and...

Cite
Baker S, Gleason F, Lovasik B, et al. Relationship between burnout and mistreatment: Who plays a role?. Am J Surg. 2021;222(6):1060-1065doi: 10.1016/j.amjsurg.2021.06.009.
Baker, S., Gleason, F., Lovasik, B., Sandhu, G., Cortez, A., Hildreth, A., Cooper, A., Simmons, J., Delman, K. A., & Lindeman, B. (2021). Relationship between burnout and mistreatment: Who plays a role?. American journal of surgery, 222(6), 1060-1065. https://doi.org/10.1016/j.amjsurg.2021.06.009
Baker, Samantha, et al. "Relationship between burnout and mistreatment: Who plays a role?." American journal of surgery vol. 222,6 (2021): 1060-1065. doi: https://doi.org/10.1016/j.amjsurg.2021.06.009
Baker S, Gleason F, Lovasik B, Sandhu G, Cortez A, Hildreth A, Cooper A, Simmons J, Delman KA, Lindeman B. Relationship between burnout and mistreatment: Who plays a role?. Am J Surg. 2021 Dec;222(6):1060-1065. doi: 10.1016/j.amjsurg.2021.06.009. Epub 2021 Jul 22. PMID: 34325910.
Copy Download .nbib Format: NLM
Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs.

Diagnostics (Basel, Switzerland)

Tan E, Frew E, Cooper J, Humphrey J, Holden M, Mand AR, Li J, Anderson S, Bi M, Hatler J, Person A, Mortari F, Gould K, Barry S.
PMID: 34208912
Diagnostics (Basel). 2021 Jun 30;11(7). doi: 10.3390/diagnostics11071190.

Identifying anti-spike antibodies that exhibit strong neutralizing activity against current dominant circulating variants, and antibodies that are escaped by these variants, has important implications in the development of therapeutic and diagnostic solutions and in improving understanding of the humoral...

Cite
Tan E, Frew E, Cooper J, et al. Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs. Diagnostics (Basel). 2021;11(7)doi: 10.3390/diagnostics11071190.
Tan, E., Frew, E., Cooper, J., Humphrey, J., Holden, M., Mand, A. R., Li, J., Anderson, S., Bi, M., Hatler, J., Person, A., Mortari, F., Gould, K., & Barry, S. (2021). Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs. Diagnostics (Basel, Switzerland), 11(7), . https://doi.org/10.3390/diagnostics11071190
Tan, Enqing, et al. "Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs." Diagnostics (Basel, Switzerland) vol. 11,7 (2021). doi: https://doi.org/10.3390/diagnostics11071190
Tan E, Frew E, Cooper J, Humphrey J, Holden M, Mand AR, Li J, Anderson S, Bi M, Hatler J, Person A, Mortari F, Gould K, Barry S. Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs. Diagnostics (Basel). 2021 Jun 30;11(7). doi: 10.3390/diagnostics11071190. PMID: 34208912; PMCID: PMC8303872.
Copy Download .nbib Format: NLM
A Population-Based Study of the Incidence, Medical Care, and Medical Expenditures for Pediatric Traumatic Brain Injury.

The Journal of surgical research

Shen J, Shi J, Cooper J, Chen C, Taylor HG, Xiang H.
PMID: 34298211
J Surg Res. 2021 Jul 19;268:87-96. doi: 10.1016/j.jss.2021.06.025. Epub 2021 Jul 19.

BACKGROUND: Traumatic brain injury (TBI) is one of the leading causes of pediatric trauma morbidity and mortality around the world. However, limited research exists regarding disparities in the incidence of TBI and medical care seeking behaviors and medical expenditures...

Cite
Shen J, Shi J, Cooper J, et al. A Population-Based Study of the Incidence, Medical Care, and Medical Expenditures for Pediatric Traumatic Brain Injury. J Surg Res. 2021;268:87-96doi: 10.1016/j.jss.2021.06.025.
Shen, J., Shi, J., Cooper, J., Chen, C., Taylor, H. G., & Xiang, H. (2021). A Population-Based Study of the Incidence, Medical Care, and Medical Expenditures for Pediatric Traumatic Brain Injury. The Journal of surgical research, 26887-96. https://doi.org/10.1016/j.jss.2021.06.025
Shen, Jiabin, et al. "A Population-Based Study of the Incidence, Medical Care, and Medical Expenditures for Pediatric Traumatic Brain Injury." The Journal of surgical research vol. 268 (2021): 87-96. doi: https://doi.org/10.1016/j.jss.2021.06.025
Shen J, Shi J, Cooper J, Chen C, Taylor HG, Xiang H. A Population-Based Study of the Incidence, Medical Care, and Medical Expenditures for Pediatric Traumatic Brain Injury. J Surg Res. 2021 Jul 19;268:87-96. doi: 10.1016/j.jss.2021.06.025. Epub 2021 Jul 19. PMID: 34298211.
Copy Download .nbib Format: NLM
Operational challenges in the COVID-19 era: Asymptomatic infections and vaccination timing.

Clinical transplantation

Axelrod DA, Ince D, Harhay MN, Mannon RB, Alhamad T, Cooper M, Josephson MA, Caliskan Y, Sharfuddin A, Kumar V, Guenette A, Schnitzler MA, Ainapurapu S, Lentine KL.
PMID: 34297878
Clin Transplant. 2021 Nov;35(11):e14437. doi: 10.1111/ctr.14437. Epub 2021 Nov 02.

The coronavirus disease 2019 (COVID-19) pandemic has created unprecedented challenges for solid organ transplant programs. While transplant activity has largely recovered, appropriate management of deceased donor candidates who are asymptomatic but have positive nucleic acid testing (NAT) for SARS-CoV-2...

Cite
Axelrod DA, Ince D, Harhay MN, et al. Operational challenges in the COVID-19 era: Asymptomatic infections and vaccination timing. Clin Transplant. 2021;35(11):e14437doi: 10.1111/ctr.14437.
Axelrod, D. A., Ince, D., Harhay, M. N., Mannon, R. B., Alhamad, T., Cooper, M., Josephson, M. A., Caliskan, Y., Sharfuddin, A., Kumar, V., Guenette, A., Schnitzler, M. A., Ainapurapu, S., & Lentine, K. L. (2021). Operational challenges in the COVID-19 era: Asymptomatic infections and vaccination timing. Clinical transplantation, 35(11), e14437. https://doi.org/10.1111/ctr.14437
Axelrod, David A, et al. "Operational challenges in the COVID-19 era: Asymptomatic infections and vaccination timing." Clinical transplantation vol. 35,11 (2021): e14437. doi: https://doi.org/10.1111/ctr.14437
Axelrod DA, Ince D, Harhay MN, Mannon RB, Alhamad T, Cooper M, Josephson MA, Caliskan Y, Sharfuddin A, Kumar V, Guenette A, Schnitzler MA, Ainapurapu S, Lentine KL. Operational challenges in the COVID-19 era: Asymptomatic infections and vaccination timing. Clin Transplant. 2021 Nov;35(11):e14437. doi: 10.1111/ctr.14437. Epub 2021 Nov 02. PMID: 34297878; PMCID: PMC8420523.
Copy Download .nbib Format: NLM
Development of the SMA independence scale-upper limb module (SMAIS-ULM): A novel scale for individuals with Type 2 and non-ambulant Type 3 SMA.

Journal of the neurological sciences

Trundell D, Skalicky A, Staunton H, Hareendran A, Le Scouiller S, Barrett L, Cooper O, Gorni K, Seabrook T, Jethwa S, Cano S.
PMID: 34896922
J Neurol Sci. 2021 Nov 25;432:120059. doi: 10.1016/j.jns.2021.120059. Epub 2021 Nov 25.

BACKGROUND: The amount of assistance required to perform daily activities for individuals with Type 2 and non-ambulant Type 3 spinal muscular atrophy (SMA) is often cited as meaningful for quality of life, and important to routinely assess.METHODS: The SMA...

Cite
Trundell D, Skalicky A, Staunton H, et al. Development of the SMA independence scale-upper limb module (SMAIS-ULM): A novel scale for individuals with Type 2 and non-ambulant Type 3 SMA. J Neurol Sci. 2021;432:120059doi: 10.1016/j.jns.2021.120059.
Trundell, D., Skalicky, A., Staunton, H., Hareendran, A., Le Scouiller, S., Barrett, L., Cooper, O., Gorni, K., Seabrook, T., Jethwa, S., & Cano, S. (2021). Development of the SMA independence scale-upper limb module (SMAIS-ULM): A novel scale for individuals with Type 2 and non-ambulant Type 3 SMA. Journal of the neurological sciences, 432120059. https://doi.org/10.1016/j.jns.2021.120059
Trundell, Dylan, et al. "Development of the SMA independence scale-upper limb module (SMAIS-ULM): A novel scale for individuals with Type 2 and non-ambulant Type 3 SMA." Journal of the neurological sciences vol. 432 (2021): 120059. doi: https://doi.org/10.1016/j.jns.2021.120059
Trundell D, Skalicky A, Staunton H, Hareendran A, Le Scouiller S, Barrett L, Cooper O, Gorni K, Seabrook T, Jethwa S, Cano S. Development of the SMA independence scale-upper limb module (SMAIS-ULM): A novel scale for individuals with Type 2 and non-ambulant Type 3 SMA. J Neurol Sci. 2021 Nov 25;432:120059. doi: 10.1016/j.jns.2021.120059. Epub 2021 Nov 25. PMID: 34896922.
Copy Download .nbib Format: NLM
Creating a culture of professional development: a milestone pathway tool for registered nurses.

Cooper E.
UIID-AD: 2687
2009;40:501-8. doi: 10.3928/00220124-20091023-07.

The nursing shortage continues to be a significant threat to health care. Creating a culture of professional development in health care institutions is one way to combat this shortage. Professional development refers to a constant commitment to maintain one's...

Cite
Cooper E. Creating a culture of professional development: a milestone pathway tool for registered nurses. 2009;40:501-8doi: 10.3928/00220124-20091023-07.
Cooper, E. (2009). Creating a culture of professional development: a milestone pathway tool for registered nurses. 40501-8. https://doi.org/10.3928/00220124-20091023-07
Cooper, E. "Creating a culture of professional development: a milestone pathway tool for registered nurses." vol. 40 (2009): 501-8. doi: https://doi.org/10.3928/00220124-20091023-07
Cooper E. Creating a culture of professional development: a milestone pathway tool for registered nurses. 2009;40:501-8. doi: 10.3928/00220124-20091023-07. UIID-AD: 2687.
Copy Download .nbib Format: NLM
Veterans Administration support for medical research: opinions of the endangered species of physician-scientists.

Zucker S, Crabbe JC, Cooper G, Finkelman F, Largman C, McCarley RW, Rice L, Rubin J, Richardson B, Seil F, Snider GL, Vandenbark AA.
UIID-AD: 325
2004;18:1481-1486. doi: 10.1096/fj.04-1573lfe.

Over the past three decades the Veterans Affairs (VA) Research program has evolved into a powerful, peer-reviewed funding mechanism for basic and translational research that has resulted in numerous important contributions to medical science and improvements in patient care....

Cite
Zucker S, Crabbe JC, Cooper G, et al. Veterans Administration support for medical research: opinions of the endangered species of physician-scientists. 2004;18:1481-1486doi: 10.1096/fj.04-1573lfe.
Zucker, S., Crabbe, J. C., Cooper, G., Finkelman, F., Largman, C., McCarley, R. W., Rice, L., Rubin, J., Richardson, B., Seil, F., Snider, G. L., & Vandenbark, A. A. (2004). Veterans Administration support for medical research: opinions of the endangered species of physician-scientists. 181481-1486. https://doi.org/10.1096/fj.04-1573lfe
Zucker, S, et al. "Veterans Administration support for medical research: opinions of the endangered species of physician-scientists." vol. 18 (2004): 1481-1486. doi: https://doi.org/10.1096/fj.04-1573lfe
Zucker S, Crabbe JC, Cooper G, Finkelman F, Largman C, McCarley RW, Rice L, Rubin J, Richardson B, Seil F, Snider GL, Vandenbark AA. Veterans Administration support for medical research: opinions of the endangered species of physician-scientists. 2004;18:1481-1486. doi: 10.1096/fj.04-1573lfe. UIID-AD: 325.
Copy Download .nbib Format: NLM
Showing 3085 to 3095 of 3095 entries